News
45m
Barchart on MSNEli Lilly vs. Novo Nordisk: Which Stock Is the Winner of the Weight-Loss Drug Boom?The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results